OBJECTIVES:: To study the clinical characteristics at diagnosis and during follow-upof
patients with the antiphospholipid syndrome (APS) and to analyze the influence of treatment …

Objective To analyze the clinical and immunologic manifestations of antiphospholipid
syndrome (APS) in a large cohort of patients and to define patterns of disease expression …

Objectives: To identify the main causes of morbidity and mortality in patients with
antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and …

Objectives To assess the prevalence of the main causes of morbi-mortality in the
antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the …

Objective To estimate the annual incidence and prevalence of and frequency of mortality
associated with antiphospholipid syndrome (APS). Methods An inception cohort of patients …

Methods Sixty pregnancies in 47 APS patients (11 primary and 36 secondary) were followed
in a multidisciplinary clinic. Patients testing antiphospholipid antibody positive and having a …

Objective. To describe morbidity, organ damage, mortality, and cause of death in patients
with antiphospholipid syndrome (APS). Methods. Descriptive analysis of 135 patients …

The study of the epidemiology of the antiphospholipid syndrome (APS) and of
antiphospholipid antibodies (aPL) is in its infancy. Classification criteria for the APS have …

OBJECTIVE: To describe a French tertiary referral center experience in the treatment of
pregnancies in patients with the antiphospholipid syndrome (APS). METHODS …

Objective. To analyze the 10 year functional outcome of primary antiphospholipid syndrome
(APS). Methods. We identified 39 patients with primary APS (35 female, 4 male) who …